Overexpression of CDC20 in tumor tissues was related with poor differentiation and a lower 5-year recurrence-free survival rate of pancreatic cancer patients (Li et al., 2003; Chang et al., 2012), and a short survival of colorectal cancer (Wu et al., 2013). This evidence concerns the gene CDC20 and familial pancreatic carcinoma.